Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,173 | 17,948 | 5,091 | 24,571 | 38,449 |
| Marketable Securities | 11,302 | 83,940 | 108,095 | 226,041 | N/A |
| Receivables | 4,752 | 9,319 | 7,022 | 4,934 | 2,775 |
| Inventories | 11,121 | 22,892 | 29,761 | 12,387 | 3,315 |
| TOTAL | $39,489 | $140,118 | $157,298 | $272,414 | $46,789 |
| Non-Current Assets | |||||
| PPE Net | 19,219 | 23,345 | 18,029 | 10,318 | 4,910 |
| Intangibles | 9,705 | 33,974 | 118,432 | 83,002 | 8,648 |
| Other Non-Current Assets | 8,257 | 16,967 | 13,743 | 11,366 | 103 |
| TOTAL | $37,181 | $74,286 | $150,204 | $104,686 | $13,661 |
| Total Assets | $76,670 | $214,404 | $307,502 | $377,100 | $60,450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,962 | 10,384 | 12,534 | 10,769 | 2,930 |
| Accrued Expenses | 5,641 | 8,089 | 10,552 | 8,621 | 5,599 |
| Other current liabilities | 1,128 | 9,317 | 10,253 | 684 | 416 |
| TOTAL | $37,344 | $100,028 | $35,884 | $21,840 | $8,945 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 16,325 |
| Other Non-Current Liabilities | 412 | 14,634 | 18,601 | 14,500 | 98 |
| TOTAL | $3,951 | $18,219 | $22,220 | $18,142 | $16,423 |
| Total Liabilities | $41,295 | $118,247 | $58,104 | $39,982 | $25,368 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,007 | 913 | 511 | 484 | 465 |
| Common Shares | N/A | N/A | 3 | 29 | 19 |
| Retained earnings | -693,225 | -581,208 | -348,715 | -216,119 | -143,684 |
| Other shareholders' equity | 27 | 23 | -1,124 | -539 | 0 |
| TOTAL | $35,375 | $96,157 | $249,398 | $337,118 | $35,082 |
| Total Liabilities And Equity | $76,670 | $214,404 | $307,502 | $377,100 | $60,450 |